Document is current
Any future updates will be listed below
-
Authors
Miyazaki, Taiga https://orcid.org/0000-0002-0962-5758
Shimamura, Shintaro
Nagayoshi, Yohsuke
Nakayama, Hironobu https://orcid.org/0000-0001-7444-1173
Morita, Akihiro
Tanaka, Yutaka https://orcid.org/0000-0003-2944-8485
Matsumoto, Yasuhiko
Inamine, Tatsuo
Nishikawa, Hiroshi
Nakada, Nana https://orcid.org/0000-0002-2508-0882
Sumiyoshi, Makoto
Hirayama, Tatsuro
Kohno, Shigeru
Mukae, Hiroshi
-
Funding
Funding for this research was provided by:
Japan Agency for Medical Research and Development (JP21fk0108094, JP24fk0108700, JP24fk0108700, JP21fk0108094)
MEXT | Japan Society for the Promotion of Science (JP19K07540)
Merck & Co., Inc. | MSD K.K. (#57467)
- License Information
-
More Information
Article History
Received: 12 February 2023
Accepted: 9 January 2025
First Online: 25 January 2025
Competing interests
: T.M. has received a research grant from MSD for this project. T.M. and H.M. have received research grants and lecture honoraria from MSD, Astellas, and Pfizer outside this work. The sponsors and pharmaceutical companies had no role in the study design; collection, analysis, and interpretation of the data; and writing of the manuscript. The other authors have no competing interests.
